Efficacy and immune-inflammatory modulation of combined glucocorticoid and anti-tuberculosis therapy in patients with bronchial asthma and pulmonary tuberculosis
American Journal of Translational Research · 2026 · 18 (4) · 2964-2976
DOI: 10.62347/hrcu4503 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Lin Fang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tuberculosis, Fuzhou Pulmonary Hospital of Fujian Fuzhou 350008, Fujian, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Tuberculosis, Fuzhou Pulmonary Hospital of Fujian Fuzhou 350008, Fujian, China.
Zitieren
APA
Fang, L., Liao, X., & Lin, J. (2026). Efficacy and immune-inflammatory modulation of combined glucocorticoid and anti-tuberculosis therapy in patients with bronchial asthma and pulmonary tuberculosis. American Journal of Translational Research, 18(4), 2964-2976. https://doi.org/10.62347/hrcu4503
Vancouver
Fang L, Liao X, Lin J. Efficacy and immune-inflammatory modulation of combined glucocorticoid and anti-tuberculosis therapy in patients with bronchial asthma and pulmonary tuberculosis. American Journal of Translational Research. 2026;18(4):2964-2976. doi:10.62347/hrcu4503
BibTeX
@article{Fang2026,
author = {Fang, Lin and Liao, Xiaoqin and Lin, Jiandong},
title = {Efficacy and immune-inflammatory modulation of combined glucocorticoid and anti-tuberculosis therapy in patients with bronchial asthma and pulmonary tuberculosis},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {4},
pages = {2964--2976},
doi = {10.62347/hrcu4503}
}
EUVIMED